Home Cart 0 Sign in  

[ CAS No. 5391-39-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 5391-39-9
Chemical Structure| 5391-39-9
Structure of 5391-39-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 5391-39-9 ]

Related Doc. of [ 5391-39-9 ]

Alternatived Products of [ 5391-39-9 ]

Product Details of [ 5391-39-9 ]

CAS No. :5391-39-9 MDL No. :MFCD00988254
Formula : C5H8N2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :JJWACYUTERPMBM-UHFFFAOYSA-N
M.W : 128.13 Pubchem ID :79350
Synonyms :
Chemical Name :1-Acetylimidazolidin-2-one

Calculated chemistry of [ 5391-39-9 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.6
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 38.35
TPSA : 49.41 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.71 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.48
Log Po/w (XLOGP3) : -0.89
Log Po/w (WLOGP) : -1.2
Log Po/w (MLOGP) : -0.52
Log Po/w (SILICOS-IT) : -0.2
Consensus Log Po/w : -0.47

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.01
Solubility : 126.0 mg/ml ; 0.982 mol/l
Class : Very soluble
Log S (Ali) : 0.33
Solubility : 277.0 mg/ml ; 2.16 mol/l
Class : Highly soluble
Log S (SILICOS-IT) : -0.28
Solubility : 66.6 mg/ml ; 0.52 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.32

Safety of [ 5391-39-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 5391-39-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 5391-39-9 ]
  • Downstream synthetic route of [ 5391-39-9 ]

[ 5391-39-9 ] Synthesis Path-Upstream   1~7

  • 1
  • [ 120-93-4 ]
  • [ 108-24-7 ]
  • [ 5391-39-9 ]
YieldReaction ConditionsOperation in experiment
64.1% at 150℃; for 1 h; 5.18 g (60.2 mmol) of 2-imidazolidone and 50 mL of acetic anhydride were added to a 100 mL recovery flask, and the mixture was stirred at an oil bath temperature of 150 ° C. for 1 hour. After cooling to room temperature, the precipitated solid was collected by filtration and washed with a small amount of cold ethanol to obtain 4.94 g (yield: 64.1percent) of colorless solid 1-acetyl-2-imidazolidone.
63% for 0.5 h; Reflux A solution of imidazolidin-2-one 1a (0.47 g, 5.3 mmol) inAc2O (4.5 mL) was refluxed for 30 min. The reaction mixture was allowed to cool down to roomtemperature, and a white precipitate was formed. The precipitate was collected by vacuumfiltration, and the filtrate was concentrated in vacuo. The combined solids obtained were purifiedby flash column chromatography (silicagel, AcOEt) to obtain 1b, as a white solid (0.43 g, 63percent)mp (EtOH) 180-181 C (Lit.41 177-178 C); IR (KBr): νmax 1654, 1725, 3259 cm-1; 1H NMR (300MHz) δ 2.47 (s, 3H), 3.47 (t, J 8.1 Hz, 2H), 3.92 (t, J 8.1 Hz, 2H), 5.87 (broad s, 1H); 13C NMR(75.5 MHz) δ 23.3, 36.4, 42.1, 157.2, 170.8; MS (CI, 230 eV) m/z (percent) 129 [MH+], 128 [M+], 85(100), 70 (10).
Reference: [1] Chemistry - A European Journal, 2002, vol. 8, # 11, p. 2464 - 2475
[2] Patent: JP2016/145198, 2016, A, . Location in patent: Paragraph 0087-0089
[3] Arkivoc, 2014, vol. 2014, # 2, p. 44 - 56
[4] Journal of the American Chemical Society, 1958, vol. 80, p. 6409,6412
  • 2
  • [ 65118-65-2 ]
  • [ 75-36-5 ]
  • [ 5391-39-9 ]
Reference: [1] Patent: US3972869, 1976, A,
[2] Patent: US3972870, 1976, A,
[3] Patent: US3983105, 1976, A,
[4] Patent: US3974141, 1976, A,
[5] Patent: US3974142, 1976, A,
[6] Patent: US3978056, 1976, A,
  • 3
  • [ 120-93-4 ]
  • [ 18773-93-8 ]
  • [ 5391-39-9 ]
Reference: [1] Synthetic Communications, 2010, vol. 40, # 24, p. 3669 - 3677
  • 4
  • [ 120-93-4 ]
  • [ 88333-03-3 ]
  • [ 75-36-5 ]
  • [ 5391-39-9 ]
Reference: [1] Organic Letters, 2003, vol. 5, # 9, p. 1531 - 1533
  • 5
  • [ 1001-53-2 ]
  • [ 124-38-9 ]
  • [ 5391-39-9 ]
Reference: [1] ChemCatChem, 2013, vol. 5, # 4, p. 1020 - 1023
  • 6
  • [ 5391-39-9 ]
  • [ 30536-19-7 ]
  • [ 64461-82-1 ]
YieldReaction ConditionsOperation in experiment
85%
Stage #1: at 60 - 65℃; for 36 h;
Stage #2: for 4 h; Reflux
Stage #3: With hydrogenchloride In ethanol at 20℃; for 1 h;
Weigh 18.6 g of 4-amino-5-chloro-2,1,3-benzothiadiazole and 15.4 g 1-Acetyl imidazolin-2-one, added to 120 mL of phosphorus oxychloride,Warm up to 60-65°C for 36 hours.The solvent is distilled off under reduced pressureAdd 160 mL of methanol to the resulting oil.The reaction was heated at reflux for 4 hours.Cold to room temperature,The reaction solution was poured into 160 mL of ice water.The aqueous sodium hydroxide solution adjusts the pH to 9-10.filter,dry.Trizanidol powdered solid 18g, yield 71percent.The resulting tizanidine is added to 100 mL of saturated hydrogen chloride ethanol solution,Stir for 1 hour at room temperature. Filtration, no filter cakeAfter washing with ethanol and drying, ethanol was recrystallized to obtain solid tizanidine hydrochloride 17.5g, the yield was 85.0percent, and the purity was 99.25percent.
Reference: [1] Patent: CN107759582, 2018, A, . Location in patent: Paragraph 0049-0051
  • 7
  • [ 5391-39-9 ]
  • [ 88474-31-1 ]
  • [ 75438-57-2 ]
Reference: [1] Patent: WO2015/11010, 2015, A1, . Location in patent: Page/Page column 17; 18
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 5391-39-9 ]

Amides

Chemical Structure| 6281-42-1

[ 6281-42-1 ]

1-(2-Aminoethyl)imidazolidin-2-one

Similarity: 0.84

Chemical Structure| 694-32-6

[ 694-32-6 ]

1-Methylimidazolidin-2-one

Similarity: 0.81

Chemical Structure| 80-73-9

[ 80-73-9 ]

1,3-Dimethylimidazolidin-2-one

Similarity: 0.81

Chemical Structure| 461-72-3

[ 461-72-3 ]

Imidazolidine-2,4-dione

Similarity: 0.76

Chemical Structure| 120-93-4

[ 120-93-4 ]

2-Imidazolidone

Similarity: 0.68

Related Parent Nucleus of
[ 5391-39-9 ]

Aliphatic Heterocycles

Chemical Structure| 6281-42-1

[ 6281-42-1 ]

1-(2-Aminoethyl)imidazolidin-2-one

Similarity: 0.84

Chemical Structure| 694-32-6

[ 694-32-6 ]

1-Methylimidazolidin-2-one

Similarity: 0.81

Chemical Structure| 461-72-3

[ 461-72-3 ]

Imidazolidine-2,4-dione

Similarity: 0.76

Chemical Structure| 87219-22-5

[ 87219-22-5 ]

2-(2-Oxoimidazolidin-1-yl)acetic acid

Similarity: 0.68

Chemical Structure| 18940-57-3

[ 18940-57-3 ]

1,1'-(Piperazine-1,4-diyl)diethanone

Similarity: 0.66

Imidazolidines

Chemical Structure| 6281-42-1

[ 6281-42-1 ]

1-(2-Aminoethyl)imidazolidin-2-one

Similarity: 0.84

Chemical Structure| 694-32-6

[ 694-32-6 ]

1-Methylimidazolidin-2-one

Similarity: 0.81

Chemical Structure| 80-73-9

[ 80-73-9 ]

1,3-Dimethylimidazolidin-2-one

Similarity: 0.81

Chemical Structure| 461-72-3

[ 461-72-3 ]

Imidazolidine-2,4-dione

Similarity: 0.76

Chemical Structure| 120-93-4

[ 120-93-4 ]

2-Imidazolidone

Similarity: 0.68